Cellromax Science Co., Ltd. (KOSDAQ:471820)
South Korea · Delayed Price · Currency is KRW 4,065.00
-40.00 (-0.97%)
At close: Sep 1, 2026
Cellromax Science Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Cash & Equivalents | 3,352 | 678.33 | 1,054 |
Short-Term Investments | 2,010 | 2,020 | 14,767 |
Trading Asset Securities | 4,063 | 5,005 | 6,910 |
Cash & Short-Term Investments | 9,424 | 7,703 | 22,732 |
Cash Growth | -31.34% | -66.11% | - |
Accounts Receivable | 752.59 | 723.54 | 531.1 |
Other Receivables | 63.5 | 93.05 | 110.04 |
Receivables | 816.09 | 816.59 | 641.14 |
Inventory | 4,785 | 5,684 | 5,186 |
Prepaid Expenses | 53.72 | 56.6 | 38.07 |
Other Current Assets | 310.21 | 120.8 | 105.36 |
Total Current Assets | 15,389 | 14,382 | 28,702 |
Property, Plant & Equipment | 3,253 | 3,509 | 3,661 |
Long-Term Investments | 28,452 | 29,184 | 10,719 |
Other Intangible Assets | 2,593 | 2,801 | 3,470 |
Long-Term Accounts Receivable | 0 | 0 | -0 |
Long-Term Deferred Tax Assets | - | - | 68.46 |
Other Long-Term Assets | 852.08 | 1,032 | 2,479 |
Total Assets | 50,538 | 50,908 | 49,100 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Accounts Payable | 778.23 | 1,609 | 1,543 |
Accrued Expenses | 471.53 | 494.9 | 426.72 |
Current Portion of Leases | 146.49 | 209.8 | 166.9 |
Current Income Taxes Payable | 582.55 | 22.92 | 562.08 |
Other Current Liabilities | 592.77 | 427.46 | 456.07 |
Total Current Liabilities | 2,572 | 2,764 | 3,154 |
Long-Term Debt | - | - | 983.07 |
Long-Term Leases | 159.62 | 268.03 | 348.21 |
Pension & Post-Retirement Benefits | - | 8.34 | 93.05 |
Long-Term Deferred Tax Liabilities | 889.28 | 949.58 | - |
Other Long-Term Liabilities | -0 | - | -0 |
Total Liabilities | 3,620 | 3,990 | 4,579 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Common Stock | 1,177 | 1,177 | 1,164 |
Additional Paid-In Capital | 6,991 | 7,050 | 13,152 |
Retained Earnings | 37,222 | 38,211 | 32,875 |
Treasury Stock | -1,696 | -2,818 | -2,670 |
Comprehensive Income & Other | 3,223 | 3,299 | -0 |
Shareholders' Equity | 46,918 | 46,918 | 44,522 |
Total Liabilities & Equity | 50,538 | 50,908 | 49,100 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Total Debt | 306.11 | 477.83 | 1,498 |
Net Cash (Debt) | 9,118 | 7,226 | 21,234 |
Net Cash Growth | -24.86% | -65.97% | - |
Net Cash Per Share | 808.43 | 633.29 | 2041.44 |
Filing Date Shares Outstanding | 11.17 | 11.16 | 11.36 |
Total Common Shares Outstanding | 11.17 | 11.16 | 11.36 |
Working Capital | 12,817 | 11,618 | 25,548 |
Book Value Per Share | 4200.49 | 4202.28 | 3920.63 |
Tangible Book Value | 44,325 | 44,117 | 41,051 |
Tangible Book Value Per Share | 3968.36 | 3951.39 | 3615.03 |
Land | - | 996.84 | 996.84 |
Buildings | - | 2,099 | 2,099 |
Machinery | - | 852.71 | 777.99 |